Mutagenetix > Incidental Mutation

Incidental Mutation 'R9016:Fen1'

686039

Institutional Source

Beutler Lab

Gene Symbol

Fen1

Ensembl Gene

ENSMUSG00000024742

Gene Name

flap structure specific endonuclease 1

Synonyms

MMRRC Submission

068846-MU

Accession Numbers

Essential gene?

Essential (E-score: 1.000) question?

Stock #

R9016 (G1)

Quality Score

225.009

Status

Validated

Chromosome

Chromosomal Location

10176496-10181533 bp(-) (GRCm39)

Type of Mutation

missense

DNA Base Change (assembly)

A to T at 10178306 bp (GRCm39)

Zygosity

Heterozygous

Amino Acid Change

Valine to Aspartic acid at position 46 (V46D)

Ref Sequence

ENSEMBL: ENSMUSP00000025651 (fasta)

Gene Model

predicted gene model for transcript(s): [ENSMUST00000010807] [ENSMUST00000025651] [ENSMUST00000040372] [ENSMUST00000116542] [ENSMUST00000142241] [ENSMUST00000156291]

AlphaFold

no structure available at present

Predicted Effect

probably benign
Transcript: ENSMUST00000010807

SMART Domains

Protein: ENSMUSP00000010807
Gene: ENSMUSG00000010663

Domain	Start	End	E-Value	Type
Cyt-b5	22	97	1.32e-19	SMART
transmembrane domain	134	156	N/A	INTRINSIC
Pfam:FA_desaturase	158	421	7.4e-35	PFAM

Predicted Effect

probably damaging
Transcript: ENSMUST00000025651
AA Change: V46D

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)

SMART Domains

Protein: ENSMUSP00000025651
Gene: ENSMUSG00000024742
AA Change: V46D

Domain	Start	End	E-Value	Type
XPGN	1	107	2.5e-60	SMART
XPGI	146	218	2.22e-34	SMART
HhH2	220	253	1.41e-13	SMART
low complexity region	354	380	N/A	INTRINSIC

Predicted Effect

probably benign
Transcript: ENSMUST00000040372

SMART Domains

Protein: ENSMUSP00000044751
Gene: ENSMUSG00000036372

Domain	Start	End	E-Value	Type
Pfam:UPF0197	3	79	3.3e-47	PFAM

Predicted Effect

probably damaging
Transcript: ENSMUST00000116542
AA Change: V46D

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)

SMART Domains

Protein: ENSMUSP00000112241
Gene: ENSMUSG00000024742
AA Change: V46D

Domain	Start	End	E-Value	Type
XPGN	1	107	2.5e-60	SMART
XPGI	146	218	2.22e-34	SMART
HhH2	220	253	1.41e-13	SMART
low complexity region	354	380	N/A	INTRINSIC

Predicted Effect

probably damaging
Transcript: ENSMUST00000142241
AA Change: V46D

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)

SMART Domains

Protein: ENSMUSP00000119221
Gene: ENSMUSG00000024742
AA Change: V46D

Domain	Start	End	E-Value	Type
XPGN	1	107	2.5e-60	SMART
XPGI	146	218	2.22e-34	SMART
HhH2	220	253	1.41e-13	SMART
low complexity region	354	380	N/A	INTRINSIC

Predicted Effect

probably damaging
Transcript: ENSMUST00000156291
AA Change: V46D

PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)

SMART Domains

Protein: ENSMUSP00000117246
Gene: ENSMUSG00000024742
AA Change: V46D

Domain	Start	End	E-Value	Type
XPGN	1	107	2.5e-60	SMART
XPGI	146	218	2.22e-34	SMART
HhH2	220	253	1.41e-13	SMART
low complexity region	354	380	N/A	INTRINSIC

Coding Region Coverage

1x: 100.0%
3x: 99.9%
10x: 99.7%
20x: 99.0%

Validation Efficiency

100% (75/75)

MGI Phenotype

FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene removes 5' overhanging flaps in DNA repair and processes the 5' ends of Okazaki fragments in lagging strand DNA synthesis. Direct physical interaction between this protein and AP endonuclease 1 during long-patch base excision repair provides coordinated loading of the proteins onto the substrate, thus passing the substrate from one enzyme to another. The protein is a member of the XPG/RAD2 endonuclease family and is one of ten proteins essential for cell-free DNA replication. DNA secondary structure can inhibit flap processing at certain trinucleotide repeats in a length-dependent manner by concealing the 5' end of the flap that is necessary for both binding and cleavage by the protein encoded by this gene. Therefore, secondary structure can deter the protective function of this protein, leading to site-specific trinucleotide expansions. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygous null mutants do not form an inner cell mass, lack DNA synthesis in blastocyst giant cells and die by embryonic day 9.5. Embryonic day 3.5 blastocysts are hypersensitive to irradiation. Heterozygotes show enhanced adenocarcinoma susceptibility. [provided by MGI curators]

Allele List at MGI

Other mutations in this stock

Total: 76 list
Gene	Ref	Var	Chr/Loc	Mutation	Predicted Effect	Zygosity
Acaa2	C	A	18: 74,932,154 (GRCm39)	S264R	probably damaging	Het
Agap1	T	C	1: 89,694,188 (GRCm39)		probably null	Het
Amer2	G	C	14: 60,617,376 (GRCm39)	D524H	probably damaging	Het
Ank1	G	A	8: 23,606,264 (GRCm39)	G1219S	probably null	Het
Apob	C	T	12: 8,035,408 (GRCm39)		silent	Het
Atg2a	G	C	19: 6,300,111 (GRCm39)	A640P	probably damaging	Het
AW209491	G	A	13: 14,812,193 (GRCm39)	V349M	probably damaging	Het
Bmpr2	C	T	1: 59,854,460 (GRCm39)	T103I	probably damaging	Het
Btaf1	A	C	19: 36,971,705 (GRCm39)	E1231D	probably benign	Het
Btbd7	T	C	12: 102,751,417 (GRCm39)	R1116G	probably damaging	Het
Catsperg1	A	T	7: 28,891,162 (GRCm39)	M627K	probably benign	Het
Cdk7	G	A	13: 100,854,126 (GRCm39)	T121I	probably benign	Het
Csmd3	T	A	15: 47,522,438 (GRCm39)	T1833S		Het
Dapk3	A	T	10: 81,028,266 (GRCm39)	R279W	probably damaging	Het
Dennd2b	A	C	7: 109,139,642 (GRCm39)	D645E	possibly damaging	Het
Dnah9	T	C	11: 65,998,856 (GRCm39)	E1064G	probably damaging	Het
Dner	T	C	1: 84,673,226 (GRCm39)	E75G	probably benign	Het
Dnmt1	T	C	9: 20,847,855 (GRCm39)	E229G	possibly damaging	Het
Fam171a1	G	A	2: 3,227,434 (GRCm39)	A856T	probably benign	Het
Fam186b	G	A	15: 99,177,616 (GRCm39)	A570V	probably damaging	Het
Ffar3	T	C	7: 30,554,454 (GRCm39)	R289G	probably damaging	Het
Fhod3	G	A	18: 25,243,136 (GRCm39)	E1165K	possibly damaging	Het
Fras1	A	T	5: 96,783,923 (GRCm39)	H809L	probably damaging	Het
Gbp7	A	T	3: 142,249,870 (GRCm39)	E447V	probably benign	Het
Gja8	T	C	3: 96,827,521 (GRCm39)	D47G	probably damaging	Het
Gm5795	A	G	14: 14,883,574 (GRCm39)	K144E	probably benign	Het
Gm7298	A	C	6: 121,758,800 (GRCm39)	Q1139H	possibly damaging	Het
Gpa33	A	T	1: 165,992,730 (GRCm39)	Y281F	probably damaging	Het
H2-M10.5	G	A	17: 37,084,226 (GRCm39)	E63K	possibly damaging	Het
Hgf	T	C	5: 16,823,956 (GRCm39)	W718R	probably damaging	Het
Ifna5	C	G	4: 88,754,046 (GRCm39)	D95E	probably benign	Het
Ifnar2	T	C	16: 91,201,073 (GRCm39)	L438P	possibly damaging	Het
Ints1	T	C	5: 139,744,326 (GRCm39)	T1479A	probably benign	Het
Kif1a	C	T	1: 92,953,395 (GRCm39)	R1263H	probably damaging	Het
Ltbp2	T	C	12: 84,856,467 (GRCm39)	T686A	probably benign	Het
Med12l	A	T	3: 59,163,294 (GRCm39)	E1307V	probably damaging	Het
Mtcl1	T	A	17: 66,651,062 (GRCm39)	T1468S	probably damaging	Het
Myo9a	C	T	9: 59,775,427 (GRCm39)	Q1013*	probably null	Het
Nckap5	T	C	1: 126,623,491 (GRCm39)	M1V	probably null	Het
Nos3	G	T	5: 24,588,639 (GRCm39)	V1122F	probably damaging	Het
Nxt2	C	T	X: 141,020,747 (GRCm39)	A118V	possibly damaging	Het
Odad1	T	G	7: 45,585,988 (GRCm39)	C128W	probably damaging	Het
Or1x6	G	A	11: 50,938,938 (GRCm39)	M1I	probably null	Het
Or52n4	A	T	7: 104,293,828 (GRCm39)	C250*	probably null	Het
Oscar	A	G	7: 3,619,072 (GRCm39)	V2A	probably benign	Het
P2rx6	T	A	16: 17,385,304 (GRCm39)	H132Q	possibly damaging	Het
Pakap	T	C	4: 57,637,857 (GRCm39)	C12R	unknown	Het
Pde6b	T	A	5: 108,536,592 (GRCm39)	M96K	possibly damaging	Het
Polq	T	A	16: 36,843,159 (GRCm39)	L231Q	probably damaging	Het
Pramel23	T	C	4: 143,423,899 (GRCm39)	I297V	possibly damaging	Het
Prrc2a	G	A	17: 35,378,844 (GRCm39)	T399I	unknown	Het
Rapsn	A	G	2: 90,867,172 (GRCm39)	D158G	probably damaging	Het
Rcor1	T	A	12: 111,047,933 (GRCm39)		probably benign	Het
Sema4d	G	T	13: 51,867,794 (GRCm39)	P186T	probably damaging	Het
Skic2	A	C	17: 35,063,640 (GRCm39)	L601R	probably damaging	Het
Slc4a7	G	A	14: 14,773,241 (GRCm38)	R737Q	probably damaging	Het
Sorbs2	T	G	8: 46,248,774 (GRCm39)	V675G	probably benign	Het
Sox15	T	G	11: 69,546,529 (GRCm39)	Y111D	probably damaging	Het
Spen	C	T	4: 141,200,938 (GRCm39)	C2563Y	probably damaging	Het
Taf8	A	T	17: 47,807,527 (GRCm39)	D153E	probably damaging	Het
Tet3	G	A	6: 83,345,253 (GRCm39)	A1728V	probably damaging	Het
Tmem232	A	T	17: 65,737,778 (GRCm39)	D427E	probably benign	Het
Tmem53	T	C	4: 117,125,451 (GRCm39)	I188T	probably benign	Het
Tnc	T	G	4: 63,935,331 (GRCm39)	D535A	probably benign	Het
Tnfrsf11a	G	A	1: 105,754,854 (GRCm39)	A309T	possibly damaging	Het
Tnik	G	A	3: 28,692,544 (GRCm39)	G867R	probably damaging	Het
Uba3	A	T	6: 97,162,694 (GRCm39)	C367*	probably null	Het
Vmn1r235	G	T	17: 21,481,969 (GRCm39)	S98I	possibly damaging	Het
Vmn2r15	T	C	5: 109,442,109 (GRCm39)	E108G	probably benign	Het
Xrra1	T	A	7: 99,525,462 (GRCm39)	I127N	probably benign	Het
Zc3h18	G	A	8: 123,129,963 (GRCm39)	R447Q	unknown	Het
Zcwpw1	C	A	5: 137,798,340 (GRCm39)	P179Q	probably damaging	Het
Zfp526	C	T	7: 24,925,264 (GRCm39)	H508Y	probably damaging	Het
Zfp583	T	C	7: 6,320,404 (GRCm39)	K203E	probably benign	Het
Zfp979	A	G	4: 147,697,504 (GRCm39)	C402R	possibly damaging	Het
Zxdc	A	G	6: 90,359,254 (GRCm39)	T629A	probably damaging	Het

Other mutations in Fen1

Allele	Source	Chr	Coord	Type	Predicted Effect	PPH Score
IGL02991:Fen1	UTSW	19	10,178,026 (GRCm39)	missense	probably benign
R3161:Fen1	UTSW	19	10,177,655 (GRCm39)	missense	probably damaging	0.96
R4245:Fen1	UTSW	19	10,177,731 (GRCm39)	missense	probably damaging	0.99
R5481:Fen1	UTSW	19	10,178,022 (GRCm39)	missense	probably damaging	1.00
R5553:Fen1	UTSW	19	10,177,787 (GRCm39)	missense	probably benign
R5733:Fen1	UTSW	19	10,178,022 (GRCm39)	missense	possibly damaging	0.86
R5783:Fen1	UTSW	19	10,178,194 (GRCm39)	nonsense	probably null
R6244:Fen1	UTSW	19	10,178,051 (GRCm39)	missense	probably damaging	1.00
R6498:Fen1	UTSW	19	10,177,479 (GRCm39)	missense	probably damaging	0.96
R6797:Fen1	UTSW	19	10,178,067 (GRCm39)	missense	probably benign	0.37
R7988:Fen1	UTSW	19	10,177,674 (GRCm39)	missense	possibly damaging	0.94
R8374:Fen1	UTSW	19	10,177,824 (GRCm39)	missense	probably benign	0.26
R9719:Fen1	UTSW	19	10,178,016 (GRCm39)	missense	probably benign	0.16

Predicted Primers

PCR Primer
(F):5'- CTGCTGCAGTTGCTTCTCAG -3'
(R):5'- CTGGTGAATGTTGCCACTTAAAAC -3'

Sequencing Primer
(F):5'- AGTTGCTTCTCAGCCTCGG -3'
(R):5'- ATGTTGCCACTTAAAACTTTTGTTCC -3'

Posted On

2021-10-11